These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1044 related items for PubMed ID: 15645132

  • 1. Integration of the hepatitis B virus X fragment in hepatocellular carcinoma and its effects on the expression of multiple molecules: a key to the cell cycle and apoptosis.
    Peng Z, Zhang Y, Gu W, Wang Z, Li D, Zhang F, Qiu G, Xie K.
    Int J Oncol; 2005 Feb; 26(2):467-73. PubMed ID: 15645132
    [Abstract] [Full Text] [Related]

  • 2. [Chronic hepatitis B virus infection and the methylation status of p16INK4A promoter].
    Zhu R, Li BZ, Ling YQ, Zhang HP, Li H, Liu Y, Hu XQ, Zhu HG.
    Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):166-70. PubMed ID: 17649629
    [Abstract] [Full Text] [Related]

  • 3. Impact of hepatitis B virus (HBV) X gene integration in liver tissue on hepatocellular carcinoma development in serologically HBV-negative chronic hepatitis C patients.
    Toyoda H, Kumada T, Kaneoka Y, Murakami Y.
    J Hepatol; 2008 Jan; 48(1):43-50. PubMed ID: 18023912
    [Abstract] [Full Text] [Related]

  • 4. Constitutive activation of nuclear factor kappaB in hepatocellular carcinoma.
    Tai DI, Tsai SL, Chang YH, Huang SN, Chen TC, Chang KS, Liaw YF.
    Cancer; 2000 Dec 01; 89(11):2274-81. PubMed ID: 11147598
    [Abstract] [Full Text] [Related]

  • 5. Differentially expressed genes associated with hepatitis B virus HBx and MHBs protein function in hepatocellular carcinoma.
    Kim DG.
    Methods Mol Biol; 2006 Dec 01; 317():141-55. PubMed ID: 16264227
    [Abstract] [Full Text] [Related]

  • 6. Human interleukin 6 gene is activated by hepatitis B virus-X protein in human hepatoma cells.
    Lee Y, Park US, Choi I, Yoon SK, Park YM, Lee YI.
    Clin Cancer Res; 1998 Jul 01; 4(7):1711-7. PubMed ID: 9676846
    [Abstract] [Full Text] [Related]

  • 7. Expression profile of nine novel genes differentially expressed in hepatitis B virus-associated hepatocellular carcinomas.
    Kim MY, Park E, Park JH, Park DH, Moon WS, Cho BH, Shin HS, Kim DG.
    Oncogene; 2001 Jul 27; 20(33):4568-75. PubMed ID: 11494152
    [Abstract] [Full Text] [Related]

  • 8. Hepatitis B virus X protein upregulates survivin expression in hepatoma tissues.
    Zhang X, Dong N, Yin L, Cai N, Ma H, You J, Zhang H, Wang H, He R, Ye L.
    J Med Virol; 2005 Nov 27; 77(3):374-81. PubMed ID: 16173017
    [Abstract] [Full Text] [Related]

  • 9. Hepatitis B virus X mutants derived from human hepatocellular carcinoma retain the ability to abrogate p53-induced apoptosis.
    Huo TI, Wang XW, Forgues M, Wu CG, Spillare EA, Giannini C, Brechot C, Harris CC.
    Oncogene; 2001 Jun 21; 20(28):3620-8. PubMed ID: 11439325
    [Abstract] [Full Text] [Related]

  • 10. Hepatitis B virus X protein sensitizes UV-induced apoptosis by transcriptional transactivation of Fas ligand gene expression.
    Kim SY, Kim JK, Kim HJ, Ahn JK.
    IUBMB Life; 2005 Sep 21; 57(9):651-8. PubMed ID: 16203685
    [Abstract] [Full Text] [Related]

  • 11. Overexpression of cyclin A in hepatocellular carcinoma and its relationship with HBx gene integration.
    Zhang Y, Peng Z, Qiu G, Wang Z, Gu W.
    Zhonghua Zhong Liu Za Zhi; 2002 Jul 21; 24(4):353-5. PubMed ID: 12408762
    [Abstract] [Full Text] [Related]

  • 12. Potent cell growth inhibitory effects in hepatitis B virus X protein positive hepatocellular carcinoma cells by the selective cyclooxygenase-2 inhibitor celecoxib.
    Xie H, Gao L, Chai N, Song J, Wang J, Song Z, Chen C, Pan Y, Zhao L, Sun S, Wu K, Feitelson MA, Liu J, Fan D.
    Mol Carcinog; 2009 Jan 21; 48(1):56-65. PubMed ID: 18506760
    [Abstract] [Full Text] [Related]

  • 13. [The expression of hepatitis B virus X protein and cyclooxygenase-2 in hepatitis B virus-related hepatocellular carcinoma: correlation with microangiogenesis and metastasis, and what is the possible mechanism].
    Liu KG, Shao XL, Xie HH, Xu L, Zhao H, Guo ZH, Li L, Liu J.
    Zhonghua Gan Zang Bing Za Zhi; 2010 Nov 21; 18(11):831-6. PubMed ID: 21138631
    [Abstract] [Full Text] [Related]

  • 14. Identification and characterization of a prevalent hepatitis B virus X protein mutant in Taiwanese patients with hepatocellular carcinoma.
    Yeh CT, Shen CH, Tai DI, Chu CM, Liaw YF.
    Oncogene; 2000 Nov 02; 19(46):5213-20. PubMed ID: 11077437
    [Abstract] [Full Text] [Related]

  • 15. Hepatitis B virus DNA integration in hepatocellular carcinoma after interferon-induced disappearance of hepatitis C virus.
    Tamori A, Nishiguchi S, Shiomi S, Hayashi T, Kobayashi S, Habu D, Takeda T, Seki S, Hirohashi K, Tanaka H, Kubo S.
    Am J Gastroenterol; 2005 Aug 02; 100(8):1748-53. PubMed ID: 16086711
    [Abstract] [Full Text] [Related]

  • 16. [Correlation between androgen receptor expression and hepatitis B virus X protein and its clinical significance in hepatocellular carcinoma].
    Gu DH, Zhu YZ, Wang X, Bai ZC, Ping JL, Chen Q, Zhu R.
    Zhonghua Zhong Liu Za Zhi; 2013 Apr 02; 35(4):282-7. PubMed ID: 23985257
    [Abstract] [Full Text] [Related]

  • 17. Aberrant epigenetic modifications in hepatocarcinogenesis induced by hepatitis B virus X protein.
    Park IY, Sohn BH, Yu E, Suh DJ, Chung YH, Lee JH, Surzycki SJ, Lee YI.
    Gastroenterology; 2007 Apr 02; 132(4):1476-94. PubMed ID: 17408664
    [Abstract] [Full Text] [Related]

  • 18. COOH-terminal truncated HBV X protein plays key role in hepatocarcinogenesis.
    Ma NF, Lau SH, Hu L, Xie D, Wu J, Yang J, Wang Y, Wu MC, Fung J, Bai X, Tzang CH, Fu L, Yang M, Su YA, Guan XY.
    Clin Cancer Res; 2008 Aug 15; 14(16):5061-8. PubMed ID: 18698024
    [Abstract] [Full Text] [Related]

  • 19. Hepatitis B virus x protein in the pathogenesis of hepatitis B virus-induced hepatocellular carcinoma.
    Kew MC.
    J Gastroenterol Hepatol; 2011 Jan 15; 26 Suppl 1():144-52. PubMed ID: 21199526
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of nuclear factor-kappaB, urokinase-type plasminogen activator, and HBx and their clinicopathological significance in hepatocellular carcinoma.
    Chan CF, Yau TO, Jin DY, Wong CM, Fan ST, Ng IO.
    Clin Cancer Res; 2004 Jun 15; 10(12 Pt 1):4140-9. PubMed ID: 15217951
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 53.